Adenylate Cyclase-Associated Protein 1 and Cofilin in Progression of Non-Small Cell Lung Cancer
- Authors: Kolegova E.S.1, Kakurina G.V.1, Kondakova I.V.1, Dobrodeev A.Y.1, Kostromitskii D.N.2, Zhuikova L.D.1
- 
							Affiliations: 
							- Tomsk National Research Medical Center, Russian Academy of Science
- Tomsk Regional Oncology Center
 
- Issue: Vol 167, No 3 (2019)
- Pages: 393-395
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/241737
- DOI: https://doi.org/10.1007/s10517-019-04534-9
- ID: 241737
Cite item
Abstract
We studied the expression of mRNA and the level of CAP1 (adenylate cyclase-associated protein 1) and cofilin proteins in the tissues of patients with non-small cell lung cancer. The expression of mRNA and the level of CAP1 in tumor tissue increased during growth of the primary tumor and its metastasis. It was shown that with the growth of the primary tumor, the content of cofilin in the tumor tissue decreases against the background of increased expression of its mRNA; in regional metastasis, the content of cofilin and expression of the corresponding mRNA increased. It was found that increased content of the studied proteins in the tumor tissue increased the risk of metastasis.
About the authors
E. S. Kolegova
Tomsk National Research Medical Center, Russian Academy of Science
							Author for correspondence.
							Email: elenakolegova@oncology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
G. V. Kakurina
Tomsk National Research Medical Center, Russian Academy of Science
														Email: elenakolegova@oncology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
I. V. Kondakova
Tomsk National Research Medical Center, Russian Academy of Science
														Email: elenakolegova@oncology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
A. Yu. Dobrodeev
Tomsk National Research Medical Center, Russian Academy of Science
														Email: elenakolegova@oncology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
D. N. Kostromitskii
Tomsk Regional Oncology Center
														Email: elenakolegova@oncology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
L. D. Zhuikova
Tomsk National Research Medical Center, Russian Academy of Science
														Email: elenakolegova@oncology.tomsk.ru
				                					                																			                												                	Russian Federation, 							Tomsk						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					